| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_34c531b0dce54fb192c75fd1f4f8d473 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-06139
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-0222 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-078 |
| filingDate |
2004-09-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2009-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9e3fa7cfa62e90f56a57fc114a426342
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_60e07d71f9c322498a2c4383ea5bcfb7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5619f8535d959bbacbe69086b458e0ab
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_abed4bac90e8a69483fe40f0b6b29b88
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_89cafc6237bac371d82eb87fac471a64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_503e8adc09ab0ddde831c4e865382dbc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_feab7d0c516eb26173a3c8158217db9b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_252eecf50ec658476ccdf78fa5707c9d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_173525cb1c4c4db90bd3f82a059fa8ce
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cd2ef0d90664350204b05664d26e2d43 |
| publicationDate |
2009-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-100497372-C |
| titleOfInvention |
Amidomethyl substituted 1-(carboxyalkyl)-cyclopentylcarbonylamino-benzazepine-N-acetic acid derivatives, process and intermediate products for their preparation and medicaments containing these compou |
| abstract |
Described are novel compounds with neutral endopeptidase (NEP) and/or human soluble endopeptidase (hSEP) inhibitory activity of the general formula (I), wherein the substituents R<1>, R<2> , R<3> and R<4> have the meanings given in the description and also medicaments containing these compounds, in particular medicaments suitable for treating or preventing cardiovascular diseases, sexual dysfunction and/or adverse conditions associated with apoptosis. |
| priorityDate |
2003-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |